High-efficiency generation and delivery of aerosols through nasal cannula during noninvasive ventilation

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 26, Issue 5, 2013, Pages 266-279

  Longest, P Worth ^a   Walenga, Ross L ^a   Son, Yoen Ju ^a   Hindle, Michael ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

computational fluid dynamics; controlled condensational growth; enhanced condensational growth aerosol delivery; in vitro aerosol testing; mesh nebulizers; nasal high flow therapy; Noninvasive ventilation aerosol delivery; submicrometer aerosols

Indexed keywords

AEROSOL; ARTICLE; ARTIFICIAL VENTILATION; COMPUTATIONAL FLUID DYNAMICS; DRUG DELIVERY DEVICE; ELECTROCARDIOGRAM; EXPERIMENT; FLOW RATE; IN VITRO STUDY; MIXER; NASAL CANNULA; NEBULIZER; NONINVASIVE VENTILATION; SIMULATION;

ADMINISTRATION, INTRANASAL; AEROSOLS; COMPUTER SIMULATION; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; HYDRODYNAMICS; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS;

EID: 84885000038     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2012.1006     Document Type: Article

References (36)

1. Lightowler JV, Wedzicha JA, Elliott MW, and Ram FSF: Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. BMJ. 2003;326:185-187. (Pubitemid 36143382)
2. Rea H, McAuley S, Jayaram L, Garrett J, Hockey H, Storey L, O'Donnell G, Haru L, Payton M, and O'Donnell K: The clinical utility of long-term humidification therapy in chronic airway disease. Respir Med. 2010;104:525-533.
3. Aboussouan LS, and Ricaurte B: Noninvasive positive pressure ventilation: increasing use in acute care. Cleve Clin J Med. 2010;77:307-316.
4. Parke RL, McGuinness SP, and Eccleston ML: A preliminary randomized controlled trial to assess effectiveness of nasal high-flow oxygen in intensive care patients. Respir Care. 2011;56:265-270.
5. Dysart K, Miller TL, Wolfson MR, and Shaffer TH: Research in high flow therapy: mechanisms of action. Respir Med. 2009;103:1400-1405.
6. Price AM, Plowright C, Makowski A, and Misztal B: Using a high-flow respiratory system (Vapotherm) within a high dependency setting. Nurs Crit Care. 2008;13:298-304.
7. Roca O, Riera J, Torres F, and Masclans JR: High-flow oxygen therapy in acute respiratory failure. Respir Care. 2010; 55:408-413.
8. Hess DR: The mask of noninvasive ventilation: principles of design and effects on aerosol delivery. J Aerosol Med. 2007; 20:S85-S99.
9. Dhand R: Aerosol delivery during mechanical ventilation: from basic techniques to new devices. J Aerosol Med Pulm Drug Deliv. 2008;21:45-60.
10. Dhand R: Aerosol therapy in patients receiving noninvasive positive pressure ventilation. J Aerosol Med Pulm Drug Deliv. 2012;25:63-78.
11. Bhashyam AR, Wolf MT, Marcinkowski AL, Saville A, Thomas K, Carcillo JA, and Corcoran TE: Aerosol delivery through nasal cannulas: an in vitro study. J Aerosol Med Pulm Drug Deliv. 2008;21:181-187.
12. Ari A, Harwood R, Sheard M, Dailey P, and Fink JB: In vitro comparison of heliox and oxygen in aerosol delivery using pediatric high flow nasal cannula. Pediatr Pulmonol. 2011; 46:795-801.
13. Cheng YS: Aerosol deposition in the extrathoracic region. Aerosol Sci Technol. 2003;37:659-671. (Pubitemid 39280174)
14. Garcia GJM, Tewksbury EW, Wong BA, and Kimbell JS: Interindividual variability in nasal filtration as a function of nasal cavity geometry. J Aerosol Med Pulm Drug Deliv. 2009;22:139-155.
15. Longest PW, Tian G, and Hindle M: Improving the lung delivery of nasally administered aerosols during noninvasive ventilation: an application of enhanced condensational growth (ECG). J Aerosol Med Pulm Drug Deliv. 2011;24: 103-118.
16. Dhand R: Inhalation therapy in invasive and noninvasive mechanical ventilation. Curr Opin Crit Care. 2007;13: 27-38. (Pubitemid 46061279)
17. Longest PW, McLeskey JT, and Hindle M: Characterization of nanoaerosol size change during enhanced condensational growth. Aerosol Sci Technol. 2010;44:473-483.
18. Hindle M, and Longest PW: Evaluation of enhanced condensational growth (ECG) for controlled respiratory drug delivery in a mouth-throat and upper tracheobronchial model. Pharm Res. 2010;27:1800-1811.
19. Tian G, Longest PW, Su G, and Hindle M: Characterization of respiratory drug delivery with enhanced condensational growth (ECG) using an individual path model of the entire tracheobronchial airways. Ann Biomed Eng. 2011;39: 1136-1153.
20. Hindle M, and Longest PW: Condensational growth of combination drug-excipient submicrometer particles for targeted high efficiency pulmonary delivery: evaluation of formulation and delivery device. J Pharm Pharmacol. 2012; 64:1254-1263.
21. Longest PW, and Hindle M: Numerical model to characterize the size increase of combination drug and hygroscopic excipient nanoparticle aerosols. Aerosol Sci Technol. 2011;45:884-899.
22. Longest PW, and Hindle M: Condensational growth of combination drug-excipient submicrometer particles: comparison of CFD predictions with experimental results. Pharm Res. 2012;29:707-721.
23. Longest PW, Spence BM, Holbrook LT, Mossi KM, Son Y-J, and Hindle M: Production of inhalable submicrometer aerosols from conventional mesh nebulizers for improved respiratory drug delivery. J Aerosol Sci. 2012;51:66-80.
24. Longest PW, and Hindle M: CFD simulations of enhanced condensational growth (ECG) applied to respiratory drug delivery with comparisons to in vitro data. J Aerosol Sci. 2010;41:805-820.
25. Longest PW, and Hindle M: Evaluation of the Respimat Soft Mist inhaler using a concurrent CFD and in vitro approach. J Aerosol Med Pulm Drug Deliv. 2009;22:99-112.
26. Longest PW, Hindle M, Das Choudhuri S, and Byron PR: Numerical simulations of capillary aerosol generation: CFD model development and comparisons with experimental data. Aerosol Sci Technol. 2007;41:952-973. (Pubitemid 47394484)
27. Longest PW, and Vinchurkar S: Validating CFD predictions of respiratory aerosol deposition: effects of upstream transition and turbulence. J Biomech. 2007;40:305-316. (Pubitemid 44958582)
28. Wilcox DC: Turbulence Modeling for CFD, 2nd ed. DCW Industries, Inc., La Cañ ada, CA; 1998.
29. Longest PW, and Xi J: Condensational growth may contribute to the enhanced deposition of cigarette smoke articles in the upper respiratory tract. Aerosol Sci Technol. 2008;42:579-602. (Pubitemid 351990145)
30. Longest PW, and Xi J: Effectiveness of direct Lagrangian tracking models for simulating nanoparticle deposition in the upper airways. Aerosol Sci Technol. 2007;41: 380-397. (Pubitemid 46393082)
31. Matida EA, Finlay WH, and Grgic LB: Improved numerical simulation of aerosol deposition in an idealized mouth-throat. J Aerosol Sci. 2004;35:1-19. (Pubitemid 37476251)
32. Longest PW, Hindle M, Das Choudhuri S, and Xi J: Comparison of ambient and spray aerosol deposition in a tandard induction port and more realistic mouth-throat geometry. J Aerosol Sci. 2008;39:572-591.
33. Vinchurkar S, and Longest PW: Evaluation of hexahedral, prismatic and hybrid mesh styles for simulating respiratory aerosol dynamics. Comput Fluids. 2008;37:317-331. (Pubitemid 350286469)
34. Longest PW, Tian G, Li X, Son Y-J, and Hindle M: Performance of combination drug and hygroscopic excipient submicrometer particles from a Softmist inhaler in a characteristic model of the airways. Ann Biomed Eng. 2012. [Epub ahead of print]
35. Tian G, Longest PW, Li X, and Hindle M: Targeting aerosol deposition to and within the lung airways using excipient enhanced growth. JAerosolMed PulmDrugDeliv. 2012 (in press).
36. Nikander K, Prince I, Coughlin S, Warren S, and TaylorG:Mode of breathing-tidal or slow and deep-through the I-neb adaptive delivery (ADD) system affects lung deposition of 99mTc-DTPA. J Aerosol Med Pulm Drug Deliv. 2010;23(S1):S37-S43.